NEW YORK – BioMérieux announced Tuesday evening that its Vidas TB-IGRA (interferon gamma release assay) has been CE marked for the diagnosis of latent TB infection.
The fully automated assay is to help in the diagnosis of Mycobacterium tuberculosis infection and is for use on BioMérieux's Vidas 3 platform. The test is fully automated from sample to result interpretation and requires one whole-blood sample tube with no manual sample preparation necessary, the Marcy L'Etoile, France-based company said.